Source: http://apps.leg.wa.gov/wac/default.aspx?cite=246-470&full=true
Timestamp: 2018-03-24 09:47:22
Document Index: 679642236

Matched Legal Cases: ['§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246', '§ 246']

Chapter 246-470 WAC: PRESCRIPTION MONITORING PROGRAM
WACs > Title 246 > Chapter 246-470
Last Update: 9/6/17
Chapter 246-470 WAC
246-470-001
246-470-010
246-470-020
Adding additional drugs to the program.
246-470-030
Data submission requirements for dispensers.
246-470-035
Dispensing and data submission requirements for veterinarians.
246-470-040
246-470-050
246-470-052
Facility and provider group access to information from the program.
246-470-060
Law enforcement, prosecutorial officials, coroners, and medical examiners' access to information from the program.
246-470-070
Other prescription monitoring program's access to information from the program.
246-470-080
Access by public or private research entities to information from the program.
246-470-090
246-470-100
These rules implement the prescription monitoring program, established by the legislature in chapter 70.225 RCW, as a means to promote the public health, safety, and welfare and to detect and prevent prescription drug abuse.
[Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-001, filed 7/27/11, effective 8/27/11.]
(7) "Patient address" means the current geographic location of the patient's residence. If the patient address is in care of another person or entity, the address of that person or entity is the "patient address" of record. When alternate addresses are possible, they must be recorded in the following order of preference:
(8) "Pharmacist" means a person licensed to engage in the practice of pharmacy.
(9) "Prescriber" means a licensed health care professional with authority to prescribe controlled substances or legend drugs.
(10) "Prescription monitoring information" means information submitted to and maintained by the prescription monitoring program.
(11) "Program" means the prescription monitoring program established under chapter 70.225 RCW.
(12) "Valid photographic identification" means:
[Statutory Authority: Chapter 70.225 RCW and 2016 c 104, and 2015 c 259. WSR 17-18-103, § 246-470-010, filed 9/6/17, effective 10/7/17. Statutory Authority: RCW 70.225.020 and 70.225.025. WSR 14-07-099, § 246-470-010, filed 3/18/14, effective 4/18/14; WSR 13-12-025, § 246-470-010, filed 5/28/13, effective 6/28/13. Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-010, filed 7/27/11, effective 8/27/11.]
Pursuant to RCW 70.225.020, the pharmacy quality assurance commission may add additional drugs to the list of drugs being monitored by the program by requesting the department amend these rules.
[Statutory Authority: RCW 70.225.020 and 70.225.025. WSR 14-07-099, § 246-470-020, filed 3/18/14, effective 4/18/14. Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-020, filed 7/27/11, effective 8/27/11.]
(3) Submitting data. A dispenser shall submit data to the department electronically, not later than one business day from the date of dispensing, and in the format required by the department. When the dispenser has not dispensed any drugs during a business day which require reporting, then within seven days the dispenser shall report that no drugs requiring reporting were dispensed. The notification shall be in a format established by the department.
(xv) When practicable, the name of the person picking up or dropping off the prescription as verified by valid photographic identification; and
[Statutory Authority: RCW 70.225.020, 70.225.025, and 70.225.040. WSR 16-15-014, § 246-470-030, filed 7/8/16, effective 8/8/16. Statutory Authority: RCW 70.225.020 and 70.225.025. WSR 14-07-099, § 246-470-030, filed 3/18/14, effective 4/18/14; WSR 13-12-025, § 246-470-030, filed 5/28/13, effective 6/28/13. Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-030, filed 7/27/11, effective 8/27/11.]
A veterinarian licensed under chapter 18.92 RCW shall provide to the department the dispensing information required by RCW 70.225.020 and as provided in this section for all schedule II, III, IV and V controlled substances and for drugs identified by the pharmacy quality assurance commission under WAC 246-470-020.
(1) Dispenser identification number. A veterinarian shall acquire and maintain a prescriber identifier issued to authorized prescribers of controlled substances by the Drug Enforcement Administration, United States Department of Justice.
(2) Submitting data. A veterinarian shall:
(a) Report data for schedule II, III, IV, and V controlled substances, and other required drugs identified by the pharmacy quality assurance commission under WAC 246-470-020, dispensed for more than a fourteen-day supply;
(b) Report data using either electronic or nonelectronic methods provided by the department;
(c) Submit data quarterly. Data must be reported on the following schedule:
(d) Report the following data elements to the department for each schedule II, III, IV, and V controlled substance and other required drugs dispensed for more than a fourteen-day supply:
(i) Name of the animal for whom the drug is dispensed including name of the animal or the animal's species (example: Feline) and the owner's last name;
(ii) Animal's date of birth, or if date of birth is unknown, enter January 1st of the estimated birth year;
(iii) Owner's name including first name, middle initial, last name, and generational suffixes, if any;
(iv) Owner's address;
(v) Drug dispensed;
(vi) Date the drug was dispensed;
(vii) Quantity and days supply dispensed;
(viii) Prescriber identifier;
(ix) Dispenser identifier; and
(x) When practicable, the identification number from a valid photo identification card of the owner.
[Statutory Authority: RCW 70.225.020 and 70.225.025. WSR 14-07-099, § 246-470-035, filed 3/18/14, effective 4/18/14; WSR 13-12-025, § 246-470-035, filed 5/28/13, effective 6/28/13.]
(5) If the connection between the facility, entity, or provider group and the health information exchanged is compromised, the facility, entity, or provider group shall notify the department's designee by telephone and in writing as soon as reasonably possible.
[Statutory Authority: Chapter 70.225 RCW and 2016 c 104, and 2015 c 259. WSR 17-18-103, § 246-470-052, filed 9/6/17, effective 10/7/17.]
Local, state, federally recognized tribe, or federal law enforcement officials and prosecutorial officials may obtain prescription monitoring information for a bona fide specific investigation involving a designated person. A local, state, federally recognized tribe, or federal coroner or medical examiner may obtain prescription monitoring information for a bona fide specific investigation to determine cause of death.
(1) Registration for access. Local, state, federally recognized tribe, or federal law enforcement officials, prosecutorial officials, coroners, and medical examiners shall register with the department in order to receive an authentication to access information from the program. The registration process shall be established by the department.
(2) Verification by the department. The department shall verify the authentication and identity of local, state, federally recognized tribe, or federal law enforcement officials, prosecutorial officials, coroners, and medical examiners before allowing access to any prescription monitoring information.
(3) Procedure for accessing prescription information. Local, state, federally recognized tribe, or federal law enforcement officials, prosecutorial officials, coroners and medical examiners may access information from the program electronically using the authentication issued by the department.
(4) Local, state, federally recognized tribe, or federal law enforcement officials and prosecutorial officials shall electronically attest that the requested information is required for a bona fide specific investigation involving a designated person prior to accessing prescription monitoring information.
(6) Local, state, federally recognized tribe, or federal law enforcement officials, prosecutorial officials, coroners and medical examiners may alternately submit a written request via mail or facsimile transmission in a format established by the department. The written request must contain an attestation that the requested information is required for a bona fide specific investigation involving a designated person or for a bona fide specific investigation to determine cause of death.
(7) Reporting lost or stolen authentication. If the authentication issued by the department is lost, missing, or the security of the authentication is compromised, the local, state, federally recognized tribe, and federal law enforcement officials, prosecutorial officials, coroners or medical examiners shall notify the department by telephone and in writing as soon as reasonably possible.
[Statutory Authority: RCW 70.225.020, 70.225.025, and 70.225.040. WSR 16-15-014, § 246-470-060, filed 7/8/16, effective 8/8/16. Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-060, filed 7/27/11, effective 8/27/11.]
Established prescription monitoring programs may obtain prescription monitoring information for requests from within their jurisdiction that do not violate the provisions of this chapter or chapter 70.225 RCW.
(1) The other prescription monitoring program must provide substantially similar protections for patient information as the protections provided in chapter 70.225 RCW.
(2) The department may share information with other prescription monitoring programs qualified under this section through a clearinghouse or prescription monitoring program information exchange that meets federal health care information privacy requirements.
(3) All requests for, uses of, and disclosures of prescription monitoring information by authorized persons must be consistent with the program's mandate as outlined in RCW 70.225.040 and this chapter.
[Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-070, filed 7/27/11, effective 8/27/11.]
(1) The department may provide prescription monitoring information in a format established by the department to any public or private entity for statistical, research, or educational purposes.
(2) Before the department releases any requested information, the department shall remove information that could be used to identify individual patients, dispensers, prescribers, and persons who received prescriptions from dispensers.
(3) To obtain information from the program a public or private entity shall submit a request in a format established by the department.
(4) All requests for, uses of, and disclosures of prescription monitoring information by the requesting entity must be consistent with the program's mandate as outlined in RCW 70.225.040 and this chapter.
[Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-080, filed 7/27/11, effective 8/27/11.]
[Statutory Authority: RCW 70.225.020, 70.225.025, and 70.225.040. WSR 16-15-014, § 246-470-090, filed 7/8/16, effective 8/8/16. Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-090, filed 7/27/11, effective 8/27/11.]
In addition to the penalties described in RCW 70.225.060, if the department determines a person has intentionally or knowingly used or disclosed prescription monitoring information in violation of chapter 70.225 RCW, the department may take action including, but not limited to:
(1) Terminating access to the program;
(2) Filing a complaint with appropriate health profession regulatory entities; or
(3) Reporting the violation to law enforcement.
[Statutory Authority: Chapter 70.225 RCW and 2007 c 259. WSR 11-16-041, § 246-470-100, filed 7/27/11, effective 8/27/11.]